Code of Good Practice in the Pharmaceutical Industry


Code of Good Practice in the Pharmaceutical Industry On 19 April 2016, the Association of European Businesses (AEB) and the Federal Antimonopoly Service (FAS) held a joint press conference to present the Code of Good Practice in the Pharmaceutical Industry. 

The Code is a set of rules governing the acceptable behaviour of participants in the pharmaceutical market. It applies to participants of the medicines market. The Code includes provisions on contractual relationships between manufacturers of drugs and buyers, the liaison procedure with distributors, commercial terms and conditions for supplying to state sector customers, settlement of disputes between the parties to the Code, and much more.

Please also see the press release in English and Russian.

Please read the full text of the Code of Good Practice in English and Russian.

The list of Companies that joined the Code of Good Practice can be downloaded in pdf HERE (latest update — 15 November 2018).
 


Back to the page "Health and Pharmaceuticals Committee"